Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer. - Wikidata - awgldk - TriplyDB

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.

http://www.wikidata.org/entity/Q37467208

about

Minimal residual disease and circulating tumor cells in breast cancer DNA hybridization detection with 100 zM sensitivity using piezoelectric plate sensors with an improved noise-reduction algorithm.Circulating mitochondrial DNA as biomarker linking environmental chemical exposure to early preclinical lesions elevation of mtDNA in human serum after exposure to carcinogenic halo-alkane-based pesticides Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic Perspectives The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy.Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.Organ Specific Tumor Markers: What's New?Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.Advances in the medical research and clinical applications on the plasma DNA Circulating nucleic acids as biomarkers in breast cancer.Tracing the origins of metastasis.Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content.Circulating nucleic acids and protease activities in blood of tumor patients.Circulating tumour cells and cell-free DNA as tools for managing breast cancer.Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients.Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood.Cell-free circulating tumor DNA analysis for breast cancer and its clinical utilization as a biomarker.Predictive value of circulating cell-free DNA in the survival of breast cancer patients: A systemic review and meta-analysis

P2860

Q27010152-01405ECA-3A73-4F13-859C-0FB8549F6068 Q27336155-9D3B0A57-7113-4E5C-A601-EACED5D01F6F Q28533510-F4836C3C-B638-4154-B4DE-FD7D99781DC8 Q33787458-A06235A1-2B89-4418-BEB3-4FC637CFF6D0 Q34613472-746EF265-1E5F-40E3-B543-F3BC3C18EE53 Q35099257-03064237-1439-478C-9F5F-DB51EE3EC28C Q35667318-8CB04369-A3FD-40B9-BB37-04CFE0A0E2B3 Q35681975-172E4840-5C15-4DE3-B25D-9463E4C0D871 Q35694373-9B6D9A7E-0C6D-48E8-AB0E-4238C332515E Q35980584-90C17495-03DE-4E3E-ADCF-645263B7E483 Q36369695-743C99F6-E93C-40F5-A1E3-1417C208132F Q36508665-A270FA7B-C62F-4E8B-8C71-F28A1640604F Q37690204-BB77E79C-C994-4C9D-86FC-6DF61B679440 Q37815132-72D5305A-6373-4445-8319-CEDD6FCC2659 Q38002456-4C9C5677-DACD-4615-A0D1-EBB6D4504596 Q38002907-7386FC44-802F-498B-A8A5-64546439BE4C Q38109808-A6FB8A6F-294D-4B13-9A36-2E19CBB5741F Q38152782-76DF3AF3-3090-4FF9-BAC9-307B58B5E7D8 Q38387142-5762FAFD-06BD-4CF9-A1D0-863D9AE1EC87 Q46670174-7183DE4E-8E6C-4AEE-BB58-6221FD24A130 Q57110507-58C2D13C-0C67-49EB-89FF-9DF4766744E6

P2860

Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer.

http://www.wikidata.org/entity/Q37467208

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Comparative evaluation of cell ...... ts with primary breast cancer.

@en

Comparative evaluation of cell ...... ts with primary breast cancer.

@nl

type

label

Comparative evaluation of cell ...... ts with primary breast cancer.

@en

Comparative evaluation of cell ...... ts with primary breast cancer.

@nl

prefLabel

Comparative evaluation of cell ...... ts with primary breast cancer.

@en

Comparative evaluation of cell ...... ts with primary breast cancer.

@nl

P1433

Q37467208-54F8729C-52CD-43BA-BBE4-6510E971E2C7

P1476

Q37467208-1936F258-2EF8-431A-B9D3-364E6B13AE8F

P2093

Q37467208-4D82709A-6C22-470D-BCEE-376EE5FA8B60

Q37467208-805883DA-CF08-4E63-A047-B8731AD6DAAA

Q37467208-C42CD315-4615-4CBF-8D12-A48650138E81

Q37467208-DF79FB40-51D4-4C53-BB42-200FF7138EE1

Q37467208-DFCFAE87-3C31-46F8-9A47-C36A8915D153

Q37467208-E7451E84-971D-446D-AE78-49C7DBE32F52

P2860

Q37467208-18BAE390-358F-4BEE-9097-8311DDF103A4

Q37467208-24543038-3525-47B3-85A0-A920E37732B0

Q37467208-3384BF7D-BB10-4067-A89A-A322EC18270A

Q37467208-38764109-12AD-4D0F-AF89-BB01C82A5B32

Q37467208-6A488343-4953-42A9-BDDE-207BADF49224

Q37467208-6ED88CA4-90F7-4581-8336-E6510C3C11FB

Q37467208-71B68FB0-1533-47E6-B906-5A391213C96F

Q37467208-79AA1D98-D3B2-4112-9C1E-FF137CA093BB

Q37467208-82A27E4F-51CA-49A5-B60B-E18233AEAFA8

Q37467208-A7F745C1-DCF1-4B0E-BE80-1F1F6D40CA2A

P2888

Q37467208-DE87B984-3E9A-4240-9842-612A33CC7127

P304

Q37467208-40991F4A-D244-4899-A1C5-368EA3276082

P31

Q37467208-D336A440-F29E-4BEB-B455-D07E0BDB1161

P356

Q37467208-E643F240-A496-45AF-9D97-4B0558B06C88

P433

Q37467208-EB9263D7-8D22-4869-B4BD-D95CA8543FCF

P478

Q37467208-CC6849A2-CA1A-41C2-8F28-F5AEA320A7CA

P50

Q37467208-704C38D6-8E15-41C7-886F-C94068C920B9

P577

Q37467208-33F6425B-4618-4C3D-997D-BF8719BCCD93

P5875

Q37467208-43D7AD32-CFD8-4F5C-9ED5-0A76ACA36820

P6179

Q37467208-6CDD7989-C56B-4E42-B7C0-FD216CE09566

P698

Q37467208-5FE55FBE-129E-496A-A5A9-B69C3E49B76E

P921

Q37467208-4CAFE112-3C1F-4076-AC76-EF58CEBD7F30

P932

Q37467208-A6DECFEF-C9AF-4AFD-9E1E-62A79A962EF8

P356

P1433

Breast Cancer Research

P1476

Comparative evaluation of cell ...... ts with primary breast cancer.

@en

P2093

Birthe Kemper

http://www.w3.org/2001/XMLSchema#string

Cord Beeger

http://www.w3.org/2001/XMLSchema#string

Friedrich Otterbach

http://www.w3.org/2001/XMLSchema#string

Heidi Schwarzenbach

http://www.w3.org/2001/XMLSchema#string

Klaus Pantel

http://www.w3.org/2001/XMLSchema#string

Rainer Kimmig

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic spread is an early step in breast cancer

About the possible origin and mechanism of circulating DNA apoptosis and active DNA release.

Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.

Genetic and cytogenetic analyses of breast cancer yield different perspectives of a complex disease.

Random mutations, selected mutations: A PIN opens the door to new genetic landscapes.

Circulating breast cancer cells are frequently apoptotic.

Dissecting the metastatic cascade.

A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer.

A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation.

Circulating nucleic acids (CNAs) and cancer--a survey.

P2888

P304

R71

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2404

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Sabine Kasimir-Bauer

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26829895

http://www.w3.org/2001/XMLSchema#string

P6179

1010345105

http://www.w3.org/2001/XMLSchema#string

P698

19772563

http://www.w3.org/2001/XMLSchema#string

P921

P932

2790848

http://www.w3.org/2001/XMLSchema#string